TCL Archive CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments January 8, 1982
TCL Archive Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk January 31, 2014
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012